// App-Quantinova.ai

F045 : Resveratrol nanoparticles are neuroprotective in vitro suggesting a potential to cure glaucoma and Alzheimer's disease

Researchers

Presenter

  • E. Shamsher

Principal Investigators

  • B. Davis

  • P. Dev

  • L. Grgic

  • S. Somavarapu

  • L. Guo

  • F. Cordeiro

Medical Centers

  • UCL Institute of Ophthalmology, Visual Neuroscience, London, UK

  • UCL School of Pharmacy, Pharmaceutics, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • Alzheimer's disease

  • Glaucoma

Biomarkers

  • N/A

Drug/Treatment

  • Resveratrol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved